Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001765581-23-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-07 | 2023-03-05 | JAZZ | Carr Patricia | SVP, CAO | S - Sale | $140.76 | -1,148 | 7,309 | -14% | -$161.6K | |
| 2023-03-07 | 2023-03-03 | JAZZ | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +2,523 | 8,457 | +43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-05 | S | D | 1,148 | $140.76 | 7,309 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $140.7559 to $140.7631. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2023-03-03 | A | A | 2,523 | $0.00 | 8,457 | D | — | — |